Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-644-9 | CAS number: 94891-43-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1 November 1983 to 3 November 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- See "Principles of method if other than guideline" below.
- Deviations:
- no
- Principles of method if other than guideline:
- AMES, B.N. et al. (1973) "Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection." Proceedings of the National Academy of Sciences 70, 2281 - 2285.
GREEN, M.H.L. and ~URIEL, W.J. (1976) "Mutagen testing using TRP+ reversion of Escherichia coli.".Mutation Research 38, 3 - 32. - GLP compliance:
- no
- Remarks:
- Study pre-dates GLP
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Nickel, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate monosodium salt, sodium salts
- EC Number:
- 305-644-9
- EC Name:
- Nickel, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate monosodium salt, sodium salts
- Cas Number:
- 94891-43-7
- Molecular formula:
- C32 H16 N8 Ni . C8 H11 N O6 S2 . 2 Na
- IUPAC Name:
- Nickel, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, chlorosulfonyl derivs., reaction products with 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate monosodium salt, sodium salts
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- No further details specified in the study report.
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- S. typhimurium TA 1538
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- 4, 20, 100, 500, 2500 and 10000 μg/plate
No justification given for top dose. - Vehicle / solvent:
- Not specified
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Aqua dest.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- other: 2-Aminoanthracene; Methylhydrazone Derivative; Streptocotocine; ENNG
- Details on test system and experimental conditions:
- The tester strains of Salmonella typhimurium TA98, TA100, TA1535, TA1537, TA1538 and Escherichia coli WP2 uvrA were maintained in liquid nitrogen and recultivated for the test in fresh nutrient broth.
The S-9 fraction was prepared from the microsomes of a liver homogenate as follows. Sprague-Dawley rats were injected once with 500 mg/kg of polychlorinated biphenyl (PCB) = Aroclor 1254 U1onsanto, S. Louis, Mo., USA) in corn oil (200 mg/ml i.p.). Five days later the animals were killed, the livers removed and homogenised in three volumes of cold 0.15 M potassium chloride. The homogenate was centrifuged at 9,000g/10 min. One ml of supernatant then contains microsomes equivalent to about 250 mg liver. The preparation was stored in liquid nitrogen until required for use. Samples were thawed immediately before each test and the S-9 Mix is prepared.
To 2 ml of molten (45°C) top agar in a sterile test-tube were added 0.1 ml of the tester strain culture, graded quantities of the test compound in 0.1 ml solution and, for the S-9 series, 0.5 ml S-9 Mix. The contents of the test-tube were rapidly mixed and poured onto the surface of previously prepared minimal agar plates with VogelBonner E mixture.
The plates were incubated upside down at 37°C for 2 days, after which the number of revertant colonies appearing was counted.
Control plates without admixture of test compound were prepared in the same way to determine the spontaneous mutation rate. - Rationale for test conditions:
- Not specfied
- Evaluation criteria:
- A chemical is considered to have a positive response if the number of induced revertants is more than double the spontaneous mutations.
- Statistics:
- Not specified
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- No unforeseen circumstances were observed which may have affected the quality or integrity of this study.
Any other information on results incl. tables
Results
μg/plate |
S-9 Mix |
Revertant colonies / plate TA 1537 |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
3 – 6 – 7 – 8 2 – 3 – 5 – 6 3 – 4 – 5 – 7 3 – 4 – 6 – 6 3 – 5 – 6 – 8 4 – 4 – 6 – 7
4 – 6 – 9 – 10 7 – 8 – 13 – 14 9 – 12 – 14 – 16 9 – 10 – 12 – 13 11 – 11 – 13 – 18 13 – 13 – 16 – 17 |
Control (Aqua dest.) 0 0 |
- + |
4 – 5 – 6 – 8 11 – 12 – 16 – 17 |
Positive controls 9-Aminoacridine 100 2-Aminoacridine 1 2-Aminoacridine 1 |
-
-
+ |
910 – 1080
7 – 9
90 – 99 |
μg/plate |
S-9 Mix |
Revertant colonies / plate TA 98 |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
16 – 22 – 24 – 24 18 – 22 – 22 – 25 16 – 20 – 20 – 22 19 – 25 – 26 – 30 18 – 22 – 24 – 24 24 – 26 – 29 – 30
23 – 30 – 34 – 35 29 – 30 – 34 – 37 29 – 35 – 37 – 43 28 – 32 – 34 – 35 33 – 35 – 39 – 43 30 – 36 – 38 – 45 |
Control (Aqua dest.) 0 0 |
- + |
17 – 21 – 23 – 24 39 – 41 – 46 – 47 |
Positive controls Methylhydrazone Derivative 5 2-Aminoacridine 0.5 2-Aminoacridine 0.5 |
-
-
+ |
3040 – 3480
25 – 25
445 – 490 |
μg/plate |
S-9 Mix |
Revertant colonies / plate TA 1538 |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
3 – 5 – 6 – 8 4 – 5 – 7 – 11 4 – 5 – 5 – 6 5 – 6 – 6 – 7 6 – 7 – 7 – 9 7 – 9 – 9 – 10
7 – 7 – 8 – 10 7 – 9 – 12 – 13 12 – 12 – 16 – 17 13 – 16 – 18 – 20 15 – 18 – 18 – 19 13 – 14 – 17 – 19 |
Control (Aqua dest.) 0 0 |
- + |
5 – 6 – 7 – 8 13 – 15 – 16 – 18 |
Positive controls Methylhydrazone Derivative 5 2-Aminoacridine 0.5 2-Aminoacridine 0.5 |
-
-
+ |
2060 – 2440
10 – 11
580 – 595 |
μg/plate |
S-9 Mix |
Revertant colonies / plate TA 100 |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
105 – 117 – 126 – 139 107 – 111 – 117 – 128 118 – 141 – 143 – 143 129 – 130 – 131 – 146 128 – 133 – 140 – 153 113 – 129 – 133 – 137
140 – 141 – 149 – 153 150 – 165 – 169 – 184 141 – 151 – 157 – 172 135 – 137 – 142 – 148 133 – 143 – 155 – 157 140 – 152 – 154 – 159 |
Control (Aqua dest.) 0 0 |
- + |
125 – 127 – 147 – 154 134 – 136 – 153 – 163 |
Positive controls Methylhydrazone Derivative 5 2-Aminoacridine 0.5 2-Aminoacridine 0.5 |
-
-
+ |
>5000 - >5000
113 – 119
570 – 630 |
μg/plate |
S-9 Mix |
Revertant colonies / plate TA 1535 |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
12 – 14 – 15 – 17 10 – 12 – 17 – 19 11 – 13 – 17 – 18 9 – 11 – 13 – 17 11 – 14 – 15 – 17 10 – 11 – 14 – 17
8 – 11 – 13 – 14 11 – 11 – 14 – 14 14 – 15 – 18 – 21 12 – 13 – 16 – 18 10 – 10 – 14 – 17 11 – 14 – 17 – 19 |
Control (Aqua dest.) 0 0 |
- + |
11 – 13 – 15 – 18 11 – 12 – 13 – 17 |
Positive controls Streptocotocine 5 2-Aminoacridine 1 2-Aminoacridine 1 |
-
-
+ |
>5000 - >5000
9 – 12
106 – 114 |
μg/plate |
S-9 Mix |
Revertant colonies / plate E.coli WP2 uvrA |
10,000 2,500 500 100 20 4
10,000 2,500 500 100 20 4 |
- - - - - -
+ + + + + + |
59 – 60 – 64 – 71 36 – 36 – 37 – 44 25 – 26 – 27 – 31 29 – 30 – 32 – 33 20 – 24 – 28 – 29 22 – 23 – 25 – 30
54 – 62 – 63 – 70 32 – 40 – 41 – 45 37 – 41 – 44 – 46 34 – 36 – 39 – 41 37 – 38 – 39 – 42 32 – 35 – 37 – 40 |
Control (Aqua dest.) 0 0 |
- + |
29 – 30 – 33 – 33 33 – 37 – 37 - 40 |
Positive controls ENNG 2 2-Aminoacridine 10 2-Aminoacridine 10 |
-
-
+ |
615 – 670
28 – 35
2380 – 2500 |
Applicant's summary and conclusion
- Conclusions:
- Under the conditions we employed Remazol-Brillantgrün 6 B in concentrations of 4 μg to 10,000 μg showed no mutagenic activity.
- Executive summary:
Compound Remazol-Brillantgrün 6 B was examined in the mutagenicity screening test in bacteria first described by Ames and co-workers.
The Ames test is a well - established screening method for mutagenic activity. Five strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537 and TA1538), auxotrophic for histidine, and one of Escherichia coli (WP2 uvrA), auxotrophic for tryptophane, were used.
No unforeseen circumstances were observed which may have affected the quality or integrity of this study.
Under the conditions we employed Remazol-Brillantgrün 6 B in concentrations of 4 μg to 10,000 μg showed no mutagenic activity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.